Elisabetta Marini

1.5k total citations
56 papers, 1.3k citations indexed

About

Elisabetta Marini is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Elisabetta Marini has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Physiology. Recurrent topics in Elisabetta Marini's work include Inflammasome and immune disorders (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Elisabetta Marini is often cited by papers focused on Inflammasome and immune disorders (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Elisabetta Marini collaborates with scholars based in Italy, Switzerland and United Kingdom. Elisabetta Marini's co-authors include Marta Giorgis, Massimo Bertinaria, Loretta Lazzarato, Barbara Rolando, Roberta Fruttero, Alberto Gasco, Clara Cena, Mattia Cocco, Gianluca Miglio and Konstantin Chegaev and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Chemistry - A European Journal.

In The Last Decade

Elisabetta Marini

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Marini Italy 21 640 321 134 132 112 56 1.3k
Gui‐Zhen Ao China 22 408 0.6× 455 1.4× 79 0.6× 111 0.8× 47 0.4× 36 1.4k
Xiaoyu Zhang China 23 957 1.5× 581 1.8× 90 0.7× 59 0.4× 51 0.5× 74 1.9k
Kimie Nakagawa Japan 22 424 0.7× 215 0.7× 72 0.5× 49 0.4× 129 1.2× 77 2.1k
Massimo Bertinaria Italy 20 644 1.0× 311 1.0× 160 1.2× 55 0.4× 113 1.0× 54 1.2k
Marta Giorgis Italy 20 646 1.0× 199 0.6× 124 0.9× 24 0.2× 80 0.7× 36 1.1k
Kevin J. Wells‐Knecht United States 20 630 1.0× 217 0.7× 76 0.6× 78 0.6× 71 0.6× 34 2.3k
Xiangbao Meng China 25 986 1.5× 877 2.7× 205 1.5× 107 0.8× 64 0.6× 103 2.1k
Jeffrey A. Robl United States 23 1.0k 1.6× 668 2.1× 90 0.7× 199 1.5× 157 1.4× 61 1.9k
Yuepiao Cai China 25 827 1.3× 351 1.1× 203 1.5× 174 1.3× 55 0.5× 66 1.7k
Hwayoung Yun South Korea 20 686 1.1× 382 1.2× 206 1.5× 101 0.8× 35 0.3× 80 1.8k

Countries citing papers authored by Elisabetta Marini

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Marini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Marini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Marini more than expected).

Fields of papers citing papers by Elisabetta Marini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Marini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Marini. The network helps show where Elisabetta Marini may publish in the future.

Co-authorship network of co-authors of Elisabetta Marini

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Marini. A scholar is included among the top collaborators of Elisabetta Marini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Marini. Elisabetta Marini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferraris, Luca, Elisabetta Marini, Elisabetta Muntoni, et al.. (2024). Concanavalin a Grafted Nanoemulsions for Nasal Delivery: Preliminary Studies with Fluorescently Labelled Formulations. Materials. 17(20). 4959–4959. 2 indexed citations
2.
Nieddu, Maria, et al.. (2024). Galactose: A Versatile Vector Unveiling the Potentials in Drug Delivery, Diagnostics, and Theranostics. Pharmaceuticals. 17(3). 308–308. 13 indexed citations
3.
Marengo, Arianna, Elisabetta Muntoni, Elisabetta Marini, et al.. (2024). Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases. Pharmaceutics. 16(8). 1051–1051. 1 indexed citations
4.
Marini, Elisabetta, Barbara Rolando, Federica Sodano, et al.. (2023). Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants. 12(2). 344–344. 8 indexed citations
5.
Rocca, Carmine, Eleonora Gianquinto, Maria Concetta Granieri, et al.. (2023). Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation. European Journal of Medicinal Chemistry. 257. 115542–115542. 22 indexed citations
6.
Marini, Elisabetta, Marco Marino, Federica Maione, et al.. (2022). Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein. Molecules. 27(23). 8513–8513. 8 indexed citations
7.
Boscaro, Valentina, Eleonora Gianquinto, Christina F. Sandall, et al.. (2021). Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor. Molecules. 26(13). 3975–3975. 10 indexed citations
8.
Muntoni, Elisabetta, Paola Milla, Elisabetta Marini, et al.. (2020). Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms. Nutrition Metabolism and Cardiovascular Diseases. 31(2). 691–698. 20 indexed citations
9.
Muntoni, Elisabetta, Elisabetta Marini, Nahid Ahmadi, et al.. (2019). Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies. Acta Diabetologica. 56(12). 1283–1292. 35 indexed citations
10.
Atlante, Sandra, Konstantin Chegaev, Chiara Cencioni, et al.. (2017). Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors. European Journal of Medicinal Chemistry. 144. 612–625. 17 indexed citations
11.
Chegaev, Konstantin, Elisabetta Marini, Barbara Rolando, et al.. (2015). NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease. Bioorganic & Medicinal Chemistry. 23(15). 4688–4698. 20 indexed citations
12.
Candia, Modesto de, et al.. (2015). New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity. European Journal of Pharmaceutical Sciences. 72. 69–80. 10 indexed citations
13.
Bertinaria, Massimo, Mattia Cocco, Davide Garella, et al.. (2014). Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs?. Pharmacology. 12(3). 1–2. 1 indexed citations
14.
Marini, Elisabetta, et al.. (2014). Probiotics supplementation and antioxidant activity in children affected by primary hyperlipidemia. Atherosclerosis. 235(2). e266–e267. 3 indexed citations
15.
Bertinaria, Massimo, Barbara Rolando, Marta Giorgis, et al.. (2012). Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile. European Journal of Medicinal Chemistry. 54. 103–112. 13 indexed citations
16.
Tamboli, Yasinalli, Loretta Lazzarato, Elisabetta Marini, et al.. (2012). Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. Bioorganic & Medicinal Chemistry Letters. 22(11). 3810–3815. 22 indexed citations
17.
Lazzarato, Loretta, Clara Cena, Barbara Rolando, et al.. (2011). Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans. Bioorganic & Medicinal Chemistry. 19(19). 5852–5860. 28 indexed citations
18.
Tosco, Paolo, Elisabetta Marini, Barbara Rolando, et al.. (2008). Structure–Antioxidant Activity Relationships in a Series of NO‐Donor Phenols. ChemMedChem. 3(9). 1443–1448. 6 indexed citations
19.
Chegaev, Konstantin, Loretta Lazzarato, Barbara Rolando, et al.. (2007). NO‐donor melatonin derivatives: synthesis and in vitro pharmacological characterization. Journal of Pineal Research. 42(4). 371–385. 12 indexed citations
20.
Tosco, Paolo, Massimo Bertinaria, Antonella Di Stilo, et al.. (2004). A new class of NO-donor H3-antagonists. Il Farmaco. 59(5). 359–371. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gui‐Zhen Ao Breakdown of academic impact, for papers by Xiaoyu Zhang Breakdown of academic impact, for papers by Kimie Nakagawa Breakdown of academic impact, for papers by Massimo Bertinaria Breakdown of academic impact, for papers by Marta Giorgis Breakdown of academic impact, for papers by Kevin J. Wells‐Knecht Breakdown of academic impact, for papers by Xiangbao Meng Breakdown of academic impact, for papers by Jeffrey A. Robl Breakdown of academic impact, for papers by Yuepiao Cai Breakdown of academic impact, for papers by Hwayoung Yun
Rankless by CCL
2026